A
An Phat Bioplastics JSC
VN:AAA
An Phat Bioplastics JSC
VN:AAA
Price:
8 850
VND
-0.23%
Market Cap:
3.4T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
AAA Alert
An Phat Bioplastics JSC
8850
-20 (-0.23%)
| 52 Week Range |
8 160
12 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
An Phat Bioplastics JSC
Balance Sheet
Balance Sheet Decomposition
An Phat Bioplastics JSC
An Phat Bioplastics JSC
| Current Assets | 7T |
| Cash & Short-Term Investments | 3.3T |
| Receivables | 1.8T |
| Other Current Assets | 1.9T |
| Non-Current Assets | 6.1T |
| Long-Term Investments | 1.6T |
| PP&E | 3T |
| Intangibles | 191.4B |
| Other Non-Current Assets | 1.3T |
| Current Liabilities | 4.1T |
| Accounts Payable | 701.3B |
| Accrued Liabilities | 215.9B |
| Short-Term Debt | 2.2T |
| Other Current Liabilities | 987.5B |
| Non-Current Liabilities | 3.8T |
| Long-Term Debt | 780B |
| Other Non-Current Liabilities | 3.1T |
Balance Sheet
An Phat Bioplastics JSC
An Phat Bioplastics JSC
Currency: VND
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
336 808
|
470 062
|
406 677
|
509 578
|
645 475
|
291 675
|
963 717
|
1 988 171
|
1 642 978
|
2 435 058
|
|
| Cash |
122 985
|
242 393
|
121 150
|
120 810
|
217 635
|
233 349
|
237 314
|
1 156 983
|
1 228 629
|
1 298 775
|
|
| Cash Equivalents |
213 823
|
227 669
|
285 527
|
388 768
|
427 840
|
58 325
|
726 403
|
831 187
|
414 349
|
1 136 283
|
|
| Short-Term Investments |
30 000
|
0
|
0
|
50 000
|
720 906
|
1 251 822
|
758 600
|
436 156
|
448 656
|
1 079 610
|
|
| Total Receivables |
177 191
|
203 363
|
299 088
|
701 689
|
1 207 592
|
1 542 394
|
1 005 192
|
1 537 616
|
1 518 103
|
1 029 912
|
|
| Accounts Receivables |
122 324
|
103 201
|
220 527
|
417 516
|
691 607
|
726 709
|
587 821
|
1 125 735
|
1 007 772
|
661 884
|
|
| Other Receivables |
54 867
|
100 161
|
78 561
|
284 173
|
515 985
|
815 685
|
417 371
|
411 881
|
510 331
|
368 028
|
|
| Inventory |
137 522
|
214 187
|
450 591
|
536 682
|
862 749
|
1 221 503
|
946 809
|
997 385
|
1 790 091
|
781 680
|
|
| Other Current Assets |
12 859
|
183 950
|
205 291
|
344 768
|
552 647
|
663 970
|
821 732
|
395 283
|
258 930
|
355 320
|
|
| Total Current Assets |
694 379
|
1 071 561
|
1 361 646
|
2 142 717
|
3 989 369
|
4 971 364
|
4 496 051
|
5 354 611
|
5 658 759
|
5 681 580
|
|
| PP&E Net |
646 876
|
786 535
|
1 553 477
|
2 301 095
|
3 321 830
|
2 292 933
|
2 606 515
|
2 875 596
|
2 693 451
|
2 160 412
|
|
| PP&E Gross |
646 876
|
786 535
|
1 553 477
|
2 301 095
|
3 321 830
|
2 292 933
|
2 606 515
|
2 875 596
|
2 693 451
|
2 160 412
|
|
| Accumulated Depreciation |
232 761
|
305 924
|
364 892
|
504 462
|
744 551
|
983 460
|
1 232 888
|
1 460 375
|
1 706 991
|
1 961 659
|
|
| Intangible Assets |
33 093
|
41 157
|
95 800
|
96 512
|
84 986
|
81 951
|
79 742
|
78 420
|
77 426
|
149 114
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
15 192
|
36 551
|
32 470
|
47 799
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
21 384
|
96 367
|
173 911
|
278 966
|
66 843
|
82 297
|
|
| Long-Term Investments |
39 205
|
42 587
|
44 339
|
0
|
48 380
|
346 376
|
935 927
|
1 096 257
|
1 991 257
|
2 646 104
|
|
| Other Long-Term Assets |
8 097
|
12 925
|
22 353
|
35 833
|
63 217
|
198 464
|
262 077
|
289 126
|
275 626
|
816 138
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
15 192
|
36 551
|
32 470
|
47 799
|
|
| Total Assets |
1 421 651
N/A
|
1 954 765
+37%
|
3 077 616
+57%
|
4 576 157
+49%
|
7 529 167
+65%
|
7 987 454
+6%
|
8 569 414
+7%
|
10 009 527
+17%
|
10 795 833
+8%
|
11 583 446
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
160 689
|
200 886
|
304 264
|
519 298
|
622 779
|
604 445
|
542 480
|
609 835
|
754 558
|
517 382
|
|
| Accrued Liabilities |
7 987
|
5 519
|
11 293
|
19 757
|
29 211
|
59 857
|
54 664
|
73 121
|
89 989
|
172 338
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
2 492 407
|
2 394 539
|
2 262 590
|
2 126 277
|
1 621 225
|
1 922 724
|
|
| Current Portion of Long-Term Debt |
329 022
|
438 770
|
800 795
|
1 417 686
|
0
|
5 548
|
680 769
|
56 904
|
266 596
|
702 769
|
|
| Other Current Liabilities |
9 976
|
21 904
|
23 933
|
34 062
|
61 707
|
172 256
|
232 333
|
416 203
|
474 115
|
421 828
|
|
| Total Current Liabilities |
507 674
|
667 079
|
1 140 285
|
1 990 804
|
3 206 103
|
3 236 646
|
3 772 835
|
3 282 339
|
3 206 483
|
3 737 041
|
|
| Long-Term Debt |
127 651
|
468 200
|
982 579
|
959 927
|
1 342 804
|
1 371 510
|
617 147
|
1 175 998
|
1 242 369
|
358 857
|
|
| Deferred Income Tax |
0
|
0
|
0
|
457
|
9
|
22 387
|
22 197
|
0
|
0
|
12 439
|
|
| Minority Interest |
9 389
|
9 922
|
10 861
|
248 117
|
399 364
|
328 341
|
426 375
|
659 891
|
651 298
|
619 705
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
101 673
|
133 274
|
96 808
|
175 796
|
1 511 238
|
|
| Total Liabilities |
644 714
N/A
|
1 145 201
+78%
|
2 133 725
+86%
|
3 199 304
+50%
|
4 948 281
+55%
|
5 060 557
+2%
|
4 971 827
-2%
|
5 215 036
+5%
|
5 275 945
+1%
|
6 239 280
+18%
|
|
| Equity | |||||||||||
| Common Stock |
396 000
|
495 000
|
569 650
|
836 000
|
1 712 000
|
1 712 000
|
2 217 600
|
3 264 345
|
3 822 745
|
3 822 745
|
|
| Retained Earnings |
187 993
|
116 439
|
161 862
|
283 770
|
265 860
|
602 686
|
568 717
|
706 494
|
721 688
|
562 623
|
|
| Additional Paid In Capital |
147 502
|
147 409
|
160 721
|
198 064
|
532 113
|
532 113
|
692 074
|
712 591
|
823 946
|
823 946
|
|
| Other Equity |
45 443
|
50 716
|
51 658
|
59 020
|
70 913
|
80 098
|
119 197
|
111 061
|
151 508
|
134 852
|
|
| Total Equity |
776 937
N/A
|
809 563
+4%
|
943 891
+17%
|
1 376 853
+46%
|
2 580 886
+87%
|
2 926 897
+13%
|
3 597 587
+23%
|
4 794 491
+33%
|
5 519 887
+15%
|
5 344 166
-3%
|
|
| Total Liabilities & Equity |
1 421 651
N/A
|
1 954 765
+37%
|
3 077 616
+57%
|
4 576 157
+49%
|
7 529 167
+65%
|
7 987 454
+6%
|
8 569 414
+7%
|
10 009 527
+17%
|
10 795 833
+8%
|
11 583 446
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
64
|
67
|
85
|
125
|
198
|
198
|
244
|
326
|
382
|
382
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
